NDC 24338-120

ERYTHROMYCIN

Erythromycin

ERYTHROMYCIN is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Arbor Pharmaceuticals, Inc.. The primary component is Erythromycin.

Product ID24338-120_6f949818-8773-4dfd-96bd-a0d67ffc92c0
NDC24338-120
Product TypeHuman Prescription Drug
Proprietary NameERYTHROMYCIN
Generic NameErythromycin
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2012-01-10
Marketing CategoryANDA / ANDA
Application NumberANDA062746
Labeler NameArbor Pharmaceuticals, Inc.
Substance NameERYTHROMYCIN
Active Ingredient Strength250 mg/1
Pharm ClassesDecreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 24338-120-13

100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24338-120-13)
Marketing Start Date2012-01-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 24338-120-13 [24338012013]

ERYTHROMYCIN CAPSULE, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA062746
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-01-10

Drug Details

Active Ingredients

IngredientStrength
ERYTHROMYCIN250 mg/1

OpenFDA Data

SPL SET ID:ddd9ad9a-fc60-409a-a2b3-be51482ef751
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310154
  • UPC Code
  • 0300746301134
  • Pharmacological Class

    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]
    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]

    Medicade Reported Pricing

    24338012013 ERYTHROMYCIN DR 250 MG CAP

    Pricing Unit: EA | Drug Type: